People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Regenesis Biomedical Inc | — | Biotechnology | Series A | $5.2M | $188.1M | 2011 |
VIRGINIA RYBSKI at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside VIRGINIA RYBSKI on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Ahrens | 1 | 3 |
| Henry Newman | 1 | 3 |
| CHUCK LUNDEN | 1 | 1 |
| JOHN VORIS | 1 | 1 |
| PETER SHEEHAN | 1 | 1 |
| TOM GREER | 1 | 1 |
| DENNIS GENGE | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.